Subscribe Here!

No More “What Ifs” - How Nektar Takes the Guesswork Out of Scaling Bioprocesses

Culture's client Nektar Therapeutics is exploring new PEG-based modifications to therapeutic...

Now is the Time to Start Using a Cloud Lab

Is COVID-19 affecting your lab operations? Run bioprocess experiments from your laptop at home...

Scaling Up from Culture’s 250mL Reactors to 5,000L and 50,000L Tanks

Modern Meadow, one of Culture Biosciences’ first customers, is biomanufacturing the next...

Best Practices in Fermentation Bioprocess Development

We spoke with Stefan De Kok, Ph. D., Director of Fermentation at Zymergen, about his experience...

Clara Foods™ Approaches Scaling Up by Scaling Down

Ranjan Patnaik, Ph. D., the Chief Technology Officer at Clara Foods, sat down with us to discuss...

Making High Purity Chemicals from Biomass

We interviewed Darcy Prather, the co-founder and President of Kalion Inc. Kalion is working to...

Supplementing In-House Bioreactor Capacity to Run High-Throughput DOEs

A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...

Early Stage Biotech Company Ran ~900 Bioreactors in First Year

Early stage biotech companies can now start running high-throughput bioreactor experiments faster.

Fixing Nitrogen: Cleaner Agriculture Through Microbial Fertilizers

Pivot Bio is working to replace synthetic nitrogen fertilizer with a cleaner and more sustainable...

Biodesigned Human Collagen Protein

For our first Customer Spotlight interview, we spoke with the Co-Founder and CEO of Geltor, Alex...

1 2